IBUPROFEN STRIDES 200 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

ibuprofen strides 200 mg

fair-med healthcare gmbh - germania - ibuprofenum - compr. film. - 200mg - antiinflamatoare si antireumatice nesteroidiene derivati de acid propionic

IBUPROFEN STRIDES 400 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

ibuprofen strides 400 mg

fair-med healthcare gmbh - germania - ibuprofenum - compr. film. - 400mg - antiinflamatoare si antireumatice nesteroidiene derivati de acid propionic

IBUPROFEN STRIDES 400 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

ibuprofen strides 400 mg

fairmed healthcare gmbh - germania - ibuprofenum - caps. moi - 400mg - antiinflamatoare si antireumatice nesteroidiene derivati de acid propionic

Lorviqua Uniunea Europeană - română - EMA (European Medicines Agency)

lorviqua

pfizer europe ma eeig - lorlatinib - carcinom, pulmonar non-celulă mică - antineoplastic agents, protein kinase inhibitors - lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. lorviqua as monotherapy is indicated for the treatment of adult patients with alk‑positive advanced nsclc whose disease has progressed after:alectinib or ceritinib as the first alk tyrosine kinase inhibitor (tki) therapy; orcrizotinib and at least one other alk tki.